Thymopentin | List of Frontiers open access articles

Original Research

Published on 15 Feb 2022

Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Peng-Cheng Yu
Di Liu
Zeng-Xiang Han
Fang Liang
Cui-Yun Hao
Yun-Tao Lei
Chang-Run Guo
Wen-Hui Wang
Xing-Hua Li
Xiao-Na Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.779715

4,893 views
6 citations

Original Research

Published on 07 May 2020

A Hybrid Peptide DEFB-TP5 Expressed in Methylotrophic Yeast Neutralizes LPS With Potent Anti-inflammatory Activities

in Experimental Pharmacology and Drug Discovery

Baseer Ahmad
Zhongxuan Li
Quratulain Hanif
Qingyong Hu
Xubiao Wei
Lulu Zhang
Shahzad Akbar Khan
Maierhaba Aihemaiti
Huma Gulzar
Muhammad Shahid

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00461

4,451 views
6 citations

Original Research

Published on 03 Jun 2020

In vitro Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation

in Industrial Biotechnology

Baseer Ahmad
Quratulain Hanif
Xubiao Wei
Lulu Zhang
Naveed Sabir
Zhongxuan Li
Junhao Cheng
Shahzad Akbar Khan
Abdul Basit
Muhammad Shahid

Frontiers in Bioengineering and Biotechnology

doi 10.3389/fbioe.2020.00454

4,225 views
7 citations

Original Research

Published on 11 Nov 2024

Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide

in Systems Immunology

Junyong Wang
Yuan Tang
Xuelian Zhao
Zetao Ding
Marhaba Ahmat
Dayong Si
Rijun Zhang
Xubiao Wei

Frontiers in Immunology

doi 10.3389/fimmu.2024.1472839

2,535 views
4 citations

Original Research

Published on 27 May 2021

Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses

in Vaccines and Molecular Therapeutics

Xubiao Wei
Lulu Zhang
Rijun Zhang
Rujuan Wu
James N. Petitte
Yanfei Hou
Dayong Si
Baseer Ahmad
Henan Guo
Manyi Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2021.620494

6,161 views
17 citations

Original Research

Published on 06 Aug 2019

Design and Development of a Novel Peptide for Treating Intestinal Inflammation

in Vaccines and Molecular Therapeutics

Lulu Zhang
Xubiao Wei
Rijun Zhang
Jim N. Petitte
Dayong Si
Zhongxuan Li
Junhao Cheng
Mengsi Du

Frontiers in Immunology

doi 10.3389/fimmu.2019.01841

14,730 views
48 citations

Original Research

Published on 05 Feb 2021

C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation

in Vaccines and Molecular Therapeutics

Lulu Zhang
Xubiao Wei
Rijun Zhang
Matthew Koci
Dayong Si
Baseer Ahmad
Henan Guo
Yanfei Hou

Frontiers in Immunology

doi 10.3389/fimmu.2020.618312

6,987 views
17 citations

Articles

Thymopentin-Mediated Inhibition of Cancer Stem Cell Stemness Enhances the Cytotoxic Effect of Oxaliplatin on Colon Cancer Cells

A Hybrid Peptide DEFB-TP5 Expressed in Methylotrophic Yeast Neutralizes LPS With Potent Anti-inflammatory Activities

In vitro Impact of Yeast Expressed Hybrid Peptide CATH-2TP5 as a Prophylactic Measure Toward Sepsis and Inflammation

Molecular hybridization modification improves the stability and immunomodulatory activity of TP5 peptide

Targeting the TLR2 Receptor With a Novel Thymopentin-Derived Peptide Modulates Immune Responses

Design and Development of a Novel Peptide for Treating Intestinal Inflammation

C-Terminal Amination of a Cationic Anti-Inflammatory Peptide Improves Bioavailability and Inhibitory Activity Against LPS-Induced Inflammation